-
1
المؤلفون: Haiko J. Bloemendal, Niven Mehra, Marco B. Polee, Joan van den Bosch, Alphonsus J. M. van den Eertwegh, Carin A. Uyl-de Groot, Daan ten Bokkel Huinink, H. P. (Pieter) van den Berg, Andre M. Bergman, Inge M. van Oort, Malou C.P. Kuppen, Addy C. M. van de Luijtgaarden, Laurent M.C.L. Fossion, Mathijs P. Hendriks, Juleon L.L.M. Coenen, Winald R. Gerritsen, Hans M. Westgeest, A.C.M. van den Bergh, Ronald de Wit, N.I. Weijl
المساهمون: Health Technology Assessment (HTA), Medical Oncology, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Medical oncology, CCA - Cancer Treatment and quality of life
المصدر: Clinical Genitourinary Cancer, 17, 5, pp. e946-e956
Clinical Genitourinary Cancer, 17(5), E946-E956. Elsevier
Clinical genitourinary cancer, 17(5), E946-E956. CIG MEDIA GROUP, LP
Westgeest, H M, Kuppen, M C P, van den Eertwegh, A J M, de Wit, R, Coenen, J L L M, van den Berg, H P, Mehra, N, van Oort, I M, Fossion, L M C L, Hendriks, M P, Bloemendal, H J, van de Luijtgaarden, A C M, ten Bokkel Huinink, D, van den Bergh, A C M, van den Bosch, J, Polee, M B, Weijl, N, Bergman, A M, Uyl-de Groot, C A & Gerritsen, W R 2019, ' Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the Netherlands ', Clinical Genitourinary Cancer, vol. 17, no. 5, pp. e946-e956 . https://doi.org/10.1016/j.clgc.2019.05.018
Clinical Genitourinary Cancer, 17(5), e946-e956. Elsevier
Clinical Genitourinary Cancer, 17, e946-e956مصطلحات موضوعية: Male, Oncology, medicine.medical_treatment, 030232 urology & nephrology, PLUS PREDNISONE, Androgen deprivation therapy, Prostate cancer, chemistry.chemical_compound, 0302 clinical medicine, Medicine, Neoplasm Metastasis, Netherlands, DOCETAXEL, Clinical Trials as Topic, education.field_of_study, CYCLES, Abiraterone acetate, Standard of Care, MEN, Middle Aged, CHEMOTHERAPY, Prognosis, OPEN-LABEL, ABIRATERONE ACETATE, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, Docetaxel, Cabazitaxel, SAFETY, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], 030220 oncology & carcinogenesis, POSTDOCETAXEL, Taxoids, medicine.drug, Registry, medicine.medical_specialty, Urology, Population, INCREASED SURVIVAL, Antineoplastic Agents, 03 medical and health sciences, Trial eligibility, SDG 3 - Good Health and Well-being, Internal medicine, Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], Humans, Real-world outcomes, education, Aged, Retrospective Studies, Chemotherapy, L-Lactate Dehydrogenase, business.industry, Prostate-Specific Antigen, medicine.disease, Survival Analysis, Trial population, Clinical trial, chemistry, business
وصف الملف: application/pdf
-
2
المؤلفون: Jorg R. Oddens, Kristel M. van Asselt, Barbara M. Wollersheim, Eric H. G. M. Oomens, Lonneke V. van de Poll-Franse, Laurent M.C.L. Fossion, Bart P. Wijsman, Mies van Eenbergen, Nicole P. M. Ezendam, Evert L. Koldewijn
المساهمون: General practice, APH - Personalized Medicine, APH - Quality of Care, CCA - Cancer Treatment and Quality of Life, Urology, APH - Health Behaviors & Chronic Diseases, Medical and Clinical Psychology
المصدر: BMC family practice, 22(1):218. BioMed Central
BMC Family Practice, Vol 22, Iss 1, Pp 1-9 (2021)
BMC Family Practice
BMC Family Practice, 22:218. BioMed Centralمصطلحات موضوعية: Male, Medicine (General), medicine.medical_specialty, LONG-TERM, QUESTIONNAIRE, Primary care, Logistic regression, NEEDS, General practitioner, Prostate cancer, R5-920, Patient satisfaction, Acquired immunodeficiency syndrome (AIDS), General Practitioners, Surveys and Questionnaires, Internal medicine, medicine, Humans, Prostate cancer survivors, Registries, Survivors, Primary Health Care, business.industry, Research, Follow-up, Prostatic Neoplasms, Cancer, medicine.disease, Cancer registry, Patient Satisfaction, HEALTH-CARE, Hormonal therapy, Primary healthcare contact, Family Practice, business
وصف الملف: application/pdf
-
3
المؤلفون: Diederik M. Somford, Reindert J.A. van Moorselaar, Carin A. Uyl-de Groot, Ronald de Wit, Laurent M.C.L. Fossion, Niven Mehra, Hans M. Westgeest, Addy C. M. van de Luijtgaarden, Juleon L.L.M. Coenen, N.I. Weijl, Maud M. Geenen, Winald R. Gerritsen, Agnes J. van de Wouw, A.C.M. van den Bergh, Mathijs P. Hendriks, Marco B. Polee, Alphonsus J. M. van den Eertwegh, Andre M. Bergman, Malou C.P. Kuppen, Inge M. van Oort, Daan ten Bokkel Huinink
المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Health Technology Assessment (HTA), Medical oncology, Urology, CCA - Cancer Treatment and quality of life, Internal medicine
المصدر: European urology oncology, 4(4), 618-627. De Tijdstroom/Elsevier
European Urology Oncology, 4, 618-627
European urology oncology, 4, 618-627. Elsevier
Kuppen, M C P, Westgeest, H M, van den Eertwegh, A J M, van Moorselaar, R J A, van Oort, I M, Coenen, J L L M, van den Bergh, A C M F, Mehra, N, Somford, D M, Bergman, A M, Ten Bokkel Huinink, D, Fossion, L, Geenen, M M, Hendriks, M P, van de Luijtgaarden, A C M, Polee, M B, Weijl, N I, van de Wouw, A J, de Wit, R, Uyl-de Groot, C A & Gerritsen, W R 2021, ' Real-world Outcomes of Sequential Androgen-receptor Targeting Therapies with or Without Interposed Life-prolonging Drugs in Metastatic Castration-resistant Prostate Cancer : Results from the Dutch Castration-resistant Prostate Cancer Registry ', European Urology Oncology, vol. 4, no. 4, pp. 618-627 . https://doi.org/10.1016/j.euo.2019.09.005
European Urology Oncology, 4, 4, pp. 618-627
European Urology Oncology, 4(4), 618-627. Elsevier BVمصطلحات موضوعية: Oncology, Male, ANTITUMOR-ACTIVITY, 030232 urology & nephrology, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Prednisone, Medicine, Sequencing, Registries, Castration-resistant prostate cancer, DOCETAXEL, Abiraterone acetate, TIME, Prostatic Neoplasms, Castration-Resistant, TRIALS, Docetaxel, Pharmaceutical Preparations, Cabazitaxel, 030220 oncology & carcinogenesis, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], Androgens, Cross resistance, medicine.drug, medicine.medical_specialty, CLINICAL-OUTCOMES, ENZALUTAMIDE, Urology, INCREASED SURVIVAL, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, Antigen, SDG 3 - Good Health and Well-being, Internal medicine, Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], Enzalutamide, Humans, Radiology, Nuclear Medicine and imaging, Real-world outcomes, Retrospective Studies, Androgen-receptor targeting agents, business.industry, Androgen Antagonists, medicine.disease, Androgen receptor, chemistry, Surgery, business
وصف الملف: application/pdf
-
4
المؤلفون: Charlotte T.J. Michels, Carl J. Wijburg, Gerjon Hannink, J. Alfred Witjes, Maroeska M. Rovers, Janneke P.C. Grutters, Sip Helder, Guus Venderbosch, Hilly Calsbeek, Ilze E.W.van Onna, Evert J. Barten, Evert L. Koldewijn, Joost L. Boormans, Bart P. Wijsman, Ronald I. Nooter, Peter J. Zwaan, Ed te Slaa, Saskia van der Meer, Sjoerd O. Klaver, Laurent M.C.L. Fossion, Siebe D. Bos, Harm H.E.van Melick, Anna M. Leliveld, Richard P. Meijer, André N. Vis, Gerard J. Molijn, Chris L. Berendsen, Jorg R. Oddens
المساهمون: Urology, CCA - Imaging and biomarkers
المصدر: European Urology Focus, 8, 3, pp. 739-747
European Urology Focus. Elsevier BV
European urology focus. Elsevier BV
Michels, C T J, Wijburg, C J, Hannink, G, Witjes, J A, Rovers, M M, Grutters, J P C, Helder, S, Venderbosch, G, Calsbeek, H, Onna, I E W V, Barten, E J, Koldewijn, E L, Boormans, J L, Wijsman, B P, Nooter, R I, Zwaan, P J, Slaa, E T, Meer, S V D, Klaver, S O, Fossion, L M C L, Bos, S D, Melick, H H E V, Leliveld, A M, Meijer, R P, Vis, A N, Molijn, G J, Berendsen, C L & Oddens, J R 2021, ' Robot-assisted Versus Open Radical Cystectomy in Bladder Cancer: An Economic Evaluation Alongside a Multicentre Comparative Effectiveness Study ', European Urology Focus . https://doi.org/10.1016/j.euf.2021.06.004
European Urology Focus, 8, 739-747مصطلحات موضوعية: medicine.medical_specialty, Complications, Cost effectiveness, Cost-Benefit Analysis, Urology, medicine.medical_treatment, Urinary Bladder, 030232 urology & nephrology, Quality-adjusted life year, Cystectomy, 03 medical and health sciences, Postoperative Complications, 0302 clinical medicine, Internal medicine, Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], Humans, Medicine, Prospective Studies, Imputation (statistics), Bladder cancer, business.industry, Standard treatment, Other Research Radboud Institute for Health Sciences [Radboudumc 0], Robotics, medicine.disease, Confidence interval, Reconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10], Radical cystectomy, Treatment Outcome, Urinary Bladder Neoplasms, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], 030220 oncology & carcinogenesis, Economic evaluation, Cost-effectiveness, Economic Evaluation, business
-
5
المؤلفون: Carl J. Wijburg, Charlotte T.J. Michels, Gerjon Hannink, Janneke P.C. Grutters, Maroeska M. Rovers, J. Alfred Witjes, Ilze E.W. van Onna, Evert J. Barten, Evert L. Koldewijn, Joost L. Boormans, Bart P. Wijsman, Ronald I. Nooter, Peter J. Zwaan, Ed te Slaa, Saskia van der Meer, Sjoerd O. Klaver, Laurent M.C.L. Fossion, Siebe D. Bos, Harm H.E.van Melick, Anna M. Leliveld, Richard P. Meijer, André N. Vis, Gerard J. Molijn, Chris L. Berendsen, Jorg R. Oddens
المصدر: European Urology, 79, 609-618
European Urology, 79(5), 609-618. ELSEVIER SCIENCE BV
European Urology, 79, 5, pp. 609-618مصطلحات موضوعية: Robot assisted, medicine.medical_specialty, Complications, Urology, medicine.medical_treatment, 030232 urology & nephrology, Effectiveness, Cystectomy, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, Postoperative Complications, 0302 clinical medicine, Robotic Surgical Procedures, Quality of life, Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], medicine, Humans, Prospective Studies, Bladder cancer, business.industry, Standard treatment, Urinary diversion, Robotics, Perioperative, medicine.disease, Confidence interval, Reconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10], Radical cystectomy, Treatment Outcome, Urinary Bladder Neoplasms, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], 030220 oncology & carcinogenesis, Propensity score matching, Quality of Life, business
وصف الملف: application/pdf
-
6
المؤلفون: Laurent M.C.L. Fossion, K. De Laet
المصدر: European Urology Open Science, Vol 19, Iss, Pp e2367-(2020)
مصطلحات موضوعية: medicine.medical_specialty, Prostatectomy, business.industry, Urology, medicine.medical_treatment, medicine, Robot, business, lcsh:Diseases of the genitourinary system. Urology, lcsh:RC870-923, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282, Surgery
-
7
المؤلفون: John van der Hoeven, Toine van der Heijden, Joost L. Boormans, Joep J. de Jong, Laurent M.C.L. Fossion, Rens Jacobs, Diederik M. Somford, Jaco Kraan, J.A. Witjes, Sjoerd O. Klaver, Ed te Slaa, Ingeborg E. de Kruijff, Peter de Vries, Nick Beije, Stefan Sleijfer, Carl Wijburg, Egbert R. Boevé, Harm H.E. van Melick, Ronald de Wit, John W.M. Martens
المصدر: Journal of Clinical Oncology. 39:4523-4523
مصطلحات موضوعية: Oncology, Cancer Research, Chemotherapy, medicine.medical_specialty, Bladder cancer, business.industry, medicine.medical_treatment, education, Muscle invasive, medicine.disease, Circulating tumor cell, Internal medicine, medicine, In patient, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b2e4aab9be3a845141e862f37115de11
https://doi.org/10.1200/jco.2021.39.15_suppl.4523 -
8
المساهمون: CCA - Cancer Treatment and Quality of Life
المصدر: International Brazilian Journal of Urology, Vol 42, Iss 6, Pp 1099-1108
International Braz J Urol, 42(6), 1099-1108. Brazilian Society of Urology
International braz j urol, Volume: 42, Issue: 6, Pages: 1099-1108, Published: DEC 2016
International braz j urol v.42 n.6 2016
International Braz J Urol
Sociedade Brasileira de Urologia (SBU)
instacron:SBU
International Brazilian Journal of Urology : official journal of the Brazilian Society of Urologyمصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Survival, Urology, medicine.medical_treatment, 030232 urology & nephrology, Cystectomy, lcsh:RC870-923, Single Center, 03 medical and health sciences, Postoperative Complications, 0302 clinical medicine, medicine, Humans, Minimally Invasive Surgical Procedures, Neoplasm Invasiveness, Complication rate, Aged, Netherlands, Retrospective Studies, Aged, 80 and over, Geriatrics, Series (stratigraphy), business.industry, Mortality rate, Middle Aged, lcsh:Diseases of the genitourinary system. Urology, humanities, Surgery, Treatment Outcome, Urinary Bladder Neoplasms, 030220 oncology & carcinogenesis, Feasibility Studies, Female, Laparoscopy, Original Article, Morbidity, business, Hospital stay
وصف الملف: text/html
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dce114607ca9a91fa842f240913d755b
https://doi.org/10.1590/s1677-5538.ibju.2015.0419 -
9
المصدر: Tijdschrift voor Urologie. 8:101-103
مصطلحات موضوعية: Urology, Philosophy, Humanities
-
10
المصدر: Urology. 125
مصطلحات موضوعية: Male, medicine.medical_specialty, Urology, 030232 urology & nephrology, Prostatic Hyperplasia, 03 medical and health sciences, 0302 clinical medicine, Prostate, medicine, Humans, Invasive Procedure, Aged, Retrospective Studies, Prostatectomy, Urinary retention, business.industry, Ultrasound, Endoscopy, Hyperplasia, medicine.disease, Surgery, medicine.anatomical_structure, Treatment Outcome, 030220 oncology & carcinogenesis, International Prostate Symptom Score, medicine.symptom, business, Complication, Benign prostate
Full Text via ClinicalKey 
Find this article in full text from Springer Verlag.